Sectors With The Most Picks
Oil, Gas and Consumable Fuels
73 Outperform
2 Underperform
Biotechnology
| Outperform | |||
|---|---|---|---|
| Ticker | Company Name | Pick Date | Score |
| View all Tickers in Tag | |||
| ASTX | Astex Pharmaceuticals, Inc. | 6/20/2012 | +148.35 |
| VRTX | Vertex Pharmaceuticals, Inc. | 3/6/2012 | +74.89 |
| ALKS | Alkermes, Inc. | 7/11/2012 | +59.80 |
| ILMN | Illumina Inc | 8/6/2012 | +51.82 |
| CELG | Celgene Corp | 5/16/2012 | +50.70 |
| AMGN | Amgen, Inc. | 3/16/2012 | +39.90 |
| XBI | SPDR S&P Biotech (ETF) | 12/19/2011 | +37.91 |
| MON | Monsanto Company | 4/27/2012 | +23.63 |
| PDLI | PDL BioPharma, Inc. | 3/26/2012 | +21.85 |
| NVS | Novartis AG (ADR) | 5/31/2012 | +19.55 |
| CBST | Cubist Pharmaceuticals, Inc. | 7/2/2012 | +8.56 |
| MDT | Medtronic, Inc. | 1/6/2012 | +2.89 |
| MYGN | Myriad Genetics, Inc. | 5/23/2012 | +1.14 |
| RPTP | Raptor Pharmaceuticals Corp. | 11/16/2012 | +0.68 |
| CCXI | ChemoCentryx, Inc. | 9/12/2012 | +0.31 |
| LIFE | Life Technologies Corporation | 3/30/2012 | -3.61 |
| NVS | Novartis AG (ADR) | 12/29/2011 | -6.61 |
| ENDP | Endo Health Solutions, Inc. | 7/11/2012 | -7.13 |
| SRPT | Sarepta Therapeutics | 10/5/2012 | -13.42 |
| MAXY | Maxygen, Inc. | 5/4/2012 | -21.88 |
| SCLN | SciClone Pharmaceuticals, Inc. | 10/2/2012 | -31.63 |
| EXEL | Exelixis, Inc. | 1/10/2012 | -35.97 |
| Underperform | |||
|---|---|---|---|
| Ticker | Company Name | Pick Date | Score |
| View all Tickers in Tag | |||
| AFFY | Affymax, Inc. | 3/28/2012 | +108.66 |
| PGNX | Progenics Pharmaceuticals, Inc. | 12/21/2011 | +83.46 |
| CTIC | Cell Therapeutics Inc | 9/13/2012 | +82.01 |
| GERN | Geron Corp | 8/31/2012 | +75.73 |
| CHTP | Chelsea Therapeutics International Ltd. | 2/17/2012 | +68.57 |
| FOLD | Amicus Therapeutics, Inc. | 2/21/2012 | +67.99 |
| PPHM | Peregrine Pharmaceuticals | 8/14/2012 | +67.83 |
| DNDN | Dendreon Corp | 6/20/2012 | +67.70 |
| PSTI | Pluristem Therapeutics, Inc. | 8/17/2012 | +55.13 |
| THLD | Threshold Pharmaceuticals, Inc. | 7/11/2012 | +54.75 |
| ANTH | Anthera Pharmaceuticals Inc | 1/17/2012 | +54.59 |
| ACUR | Acura Pharmaceuticals Inc. | 12/12/2012 | +46.81 |
| OSIR | Osiris Therapeutics, Inc. | 6/27/2012 | +44.58 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 7/20/2012 | +42.40 |
| SRPT | Sarepta Therapeutics | 3/20/2012 | +41.08 |
| AVNR | AVANIR Pharmaceuticals | 7/6/2012 | +38.10 |
| SNTA | Synta Pharmaceuticals Corp. | 2/19/2013 | +29.78 |
| DEPO | DepoMed, Inc. | 2/19/2013 | +29.56 |
| SNSS | Sunesis Pharmaceuticals, Inc. | 10/8/2012 | +27.71 |
| NVAX | Novavax, Inc. | 7/13/2012 | +25.70 |
| OREX | Orexigen Therapeutics, Inc. | 6/29/2012 | +23.97 |
| INCY | Incyte Corp | 6/11/2012 | +22.74 |
| OPTR | Optimer Pharmaceuticals Inc | 4/10/2012 | +6.21 |
| NBIX | Neurocrine Biosciences, Inc. | 3/13/2012 | -24.01 |
| HPTX | Hyperion Therapeutics | 1/22/2013 | -36.82 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 2/8/2012 | -63.64 |
| ONXX | Onyx Pharmaceuticals, Inc. | 6/19/2012 | -93.50 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 6/13/2012 | -113.48 |
| CLVS | Clovis Oncology | 12/6/2012 | -118.52 |
| REGN | Regeneron Pharmaceuticals, Inc. | 2/16/2012 | -123.67 |
| ARNA | Arena Pharmaceuticals, Inc. | 5/4/2012 | -160.46 |
| INFI | Infinity Pharmaceuticals, Inc. | 2/29/2012 | -189.80 |
Metals and Mining
35 Outperform
2 Underperform
Specialty Retail
22 Outperform
15 Underperform
Pharmaceuticals
19 Outperform
11 Underperform
Software
21 Outperform
8 Underperform
Machinery
28 Outperform
0 Underperform
Semiconductors and Semiconductor Equipment
19 Outperform
6 Underperform
Energy Equipment and Services
24 Outperform
0 Underperform
Chemicals
22 Outperform
0 Underperform
Healthcare Equipment and Supplies
19 Outperform
3 Underperform
Food Products
17 Outperform
4 Underperform
Communications Equipment
17 Outperform
4 Underperform
Hotels, Restaurants and Leisure
12 Outperform
6 Underperform
Capital Markets
16 Outperform
2 Underperform
Computers and Peripherals
12 Outperform
4 Underperform
Beverages
14 Outperform
2 Underperform
Media
5 Outperform
10 Underperform
Aerospace and Defense
14 Outperform
1 Underperform
Insurance
14 Outperform
0 Underperform
Real Estate Investment Trusts (REITs)
9 Outperform
5 Underperform
Food and Staples Retailing
12 Outperform
1 Underperform
Internet Software and Services
8 Outperform
5 Underperform
Electronic Equipment, Instruments and Components
11 Outperform
1 Underperform
Household Durables
4 Outperform
8 Underperform
Electrical Equipment
7 Outperform
4 Underperform
Commercial Banks
9 Outperform
2 Underperform
Electric Utilities
11 Outperform
0 Underperform
IT Services
11 Outperform
0 Underperform
Leisure Equipment and Products
10 Outperform
0 Underperform
Commercial Services and Supplies
10 Outperform
0 Underperform
Construction and Engineering
9 Outperform
0 Underperform
Road and Rail
9 Outperform
0 Underperform
Textiles, Apparel and Luxury Goods
6 Outperform
3 Underperform
Healthcare Providers and Services
8 Outperform
0 Underperform
Industrial Conglomerates
8 Outperform
0 Underperform
Multiline Retail
3 Outperform
5 Underperform
Diversified Telecommunication Services
8 Outperform
0 Underperform
Tobacco
6 Outperform
2 Underperform
Internet and Catalog Retail
1 Outperform
5 Underperform
Wireless Telecommunication Services
6 Outperform
0 Underperform
Auto Components
6 Outperform
0 Underperform
Dedicated Short Bias Funds
1 Outperform
5 Underperform
Diversified Financial Services
5 Outperform
0 Underperform
Diversified Consumer Services
3 Outperform
2 Underperform
Life Sciences Tools and Services
5 Outperform
0 Underperform
Marine
5 Outperform
0 Underperform
Trading Companies and Distributors
3 Outperform
2 Underperform
Airlines
1 Outperform
4 Underperform
Professional Services
1 Outperform
4 Underperform
Personal Products
1 Outperform
3 Underperform
Multi-Utilities
4 Outperform
0 Underperform
Household Products
4 Outperform
0 Underperform
Containers and Packaging
3 Outperform
0 Underperform
Independent Power Producers and Energy Traders
3 Outperform
0 Underperform
Air Freight and Logistics
3 Outperform
0 Underperform
Paper and Forest Products
3 Outperform
0 Underperform
Automobiles
3 Outperform
0 Underperform
Specialty/Miscellaneous Funds
2 Outperform
1 Underperform
Building Products
2 Outperform
0 Underperform
Gas Utilities
2 Outperform
0 Underperform
International Income Funds
0 Outperform
2 Underperform
Distributors
1 Outperform
1 Underperform
Construction Materials
2 Outperform
0 Underperform
Consumer Finance
2 Outperform
0 Underperform
Emerging Markets Funds
2 Outperform
0 Underperform
Short Municipal Debt Funds
0 Outperform
2 Underperform
Natural Resources Funds
2 Outperform
0 Underperform
General U.S. Treasury Funds
0 Outperform
2 Underperform
Gold Oriented Funds
0 Outperform
2 Underperform
Health/Biotechnology Funds
2 Outperform
0 Underperform
Latin American Funds
1 Outperform
0 Underperform
International Multi-Cap Growth
1 Outperform
0 Underperform
High Current Yield Funds
0 Outperform
1 Underperform
International Large-Cap Core
1 Outperform
0 Underperform
International Multi-Cap Core
1 Outperform
0 Underperform
Thrifts and Mortgage Finance
1 Outperform
0 Underperform
Office Electronics
1 Outperform
0 Underperform
Real Estate Management and Development
1 Outperform
0 Underperform
Consumer Goods Funds
1 Outperform
0 Underperform
Short Investment Grade Debt Funds
0 Outperform
1 Underperform
Treasury Inflation Protected Securities
0 Outperform
1 Underperform
Industrials Funds
1 Outperform
0 Underperform
Commodities Funds
0 Outperform
1 Underperform
New York Municipal Debt Funds
0 Outperform
1 Underperform
Sector Equity Funds
1 Outperform
0 Underperform
Health Care Technology
1 Outperform
0 Underperform
Transportation Infrastructure
0 Outperform
0 Underperform








RSS Headlines
Fool UK